ArticleBreast cancer research : BCR2025

Impact of germline BRCA1/2 mutations on response to neoadjuvant systemic therapy and prognosis in breast cancer: a propensity score matched cohort study.

Hyunyou Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.